PrednisoneVincristineCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsMechlorethaminePrednisoloneAzathioprineImmunosuppressive AgentsTreatment OutcomeMelphalanMitoxantroneDrug Therapy, CombinationAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsDrug Administration ScheduleBleomycinMethotrexateColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinCyclosporineHodgkin DiseaseLymphoma, Large B-Cell, DiffuseAdministration, OralMycophenolic AcidTime FactorsVinblastineAdrenal Cortex HormonesFollow-Up StudiesAsparaginaseMultiple MyelomaThalidomideKidney TransplantationEtoposideSurvival AnalysisRecurrenceGraft RejectionTacrolimusDisease-Free SurvivalMethylprednisoloneSurvival RateCombined Modality TherapyNephrotic SyndromeDose-Response Relationship, DrugCyclosporins6-MercaptopurinePolymyalgia RheumaticaClinical Trials as TopicEtiocholanoloneLymphoma, FollicularVindesineCarmustinePrognosisProspective StudiesRetrospective StudiesAndrostenolsTaxoidsImmunosuppressionDouble-Blind MethodAdrenocortical HyperfunctionRaccoon DogsCapillary FragilityLomustineDexamethasoneBoronic AcidsEstramustinePyrazinesThrombocytopeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, HormonalArthritis, RheumatoidGraft SurvivalRemission, SpontaneousProstatic NeoplasmsAntibodies, MonoclonalOrchiectomyFluoxymesterone